No longer will they be paid for speaking at meetings or for sitting on advisory boards. They may still work with companies. It is important, they say, for knowledgeable scientists to help companies draw up and interpret studies. But the work will be pro bono.Click here to access.
Monday, April 14, 2008
The start of a trend?
Check out the New York Times article "Citing Ethics, Some Doctors Are Rejecting Industry Pay"; an excerpt: